NCT06284421

Brief Summary

This study will evaluate the use of a durometer to measure uterine tone in parturients undergoing cesarean delivery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
4mo left

Started Feb 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Feb 2024Aug 2026

Study Start

First participant enrolled

February 8, 2024

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

February 13, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

February 29, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2026

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2026

Expected
Last Updated

May 6, 2025

Status Verified

May 1, 2025

Enrollment Period

2.1 years

First QC Date

February 13, 2024

Last Update Submit

May 5, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • feasibility of a durometer

    The primary outcome will be the ability to obtain reliable readings of the 'hardness' of the uterus during a cesarean delivery.

    within 10 minutes after placental delivery

Secondary Outcomes (6)

  • durometer reading

    0 minutes after placental delivery

  • durometer reading

    3 minutes after placental delivery

  • durometer reading

    10 minutes after placental delivery

  • correlation of durometer reading with a 0-10 uterine tone rating score (0= "no tone"; 10= "excellent tone")

    0 minutes after placental delivery

  • correlation of durometer reading with a 0-10 uterine tone rating score (0= "no tone"; 10= "excellent tone")

    3 minutes after placental delivery

  • +1 more secondary outcomes

Study Arms (1)

Durometer

EXPERIMENTAL

This is a single-arm trial in which a Shore durometer will be used to measure the hardness of the uterus after placental delivery during cesarean section.

Device: Shore durometer

Interventions

The durometer will be held on the exterior of the lower uterine segment and fundus to measure the hardness reading at each location.

Durometer

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Non-emergent (scheduled) cesarean delivery at University of Chicago Family Birth Center
  • Patients ages 18-50

You may not qualify if:

  • Patients undergoing unscheduled (intrapartum) cesarean delivery
  • Ages \<18 or \>50 years old
  • Intrapartum cesarean hysterectomy
  • Inability to provide independent, informed consent due to impairment or intellectual disability
  • Non-English speaking patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Chicago

Chicago, Illinois, 60637, United States

RECRUITING

Study Officials

  • Naida Cole, MD

    University of Chicago

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Model Details: To determine the feasibility of using a portable, digital Shore OO durometer to measure uterine tone during elective cesarean delivery. We hypothesize that this durometer will be easy to use by operating obstetricians for the measurement of uterine tone during cesarean delivery. Also we hope to be to correlate the hardness of uterine tone, as measured by the Shore OO durometer, with a 0-10 score on the uterine tone score and the administration of extra uterotonic drugs for uterine atony. \[NB- the administration of extra uterotonic drugs is dependent on the clinical decision made by the obstetrician in agreement with the anesthesiologist.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 13, 2024

First Posted

February 29, 2024

Study Start

February 8, 2024

Primary Completion

March 30, 2026

Study Completion (Estimated)

August 30, 2026

Last Updated

May 6, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations